Introduction: Thyroid nodular goitre is one of the most common endocrine disorders. Differentiating between benign and malignant lesions is an emerging challenge in endocrinological practice. Ultrasonography (US) remains the most commonly applied method in the preliminary assessment of lesions and is the basis for the decision as to fine needle aspiration biopsy (FNAB) and further diagnostics. Many studies have evaluated the diagnostic value of US malignancy features. However, they focused mainly on papillary thyroid cancer (PTC). It remains unclear whether other types of thyroid carcinoma (TC) are also characterised by the same US features. The aim of this study was to assess the usefulness of US features considered as markers in the diagnosis of medullary thyroid cancer (MTC).
Introduction
Thyroid nodular goitre is one of the most common endocrine disorders [1, 2] . Differentiating between benign and malignant lesions is an emerging challenge in endocrine practice. Ultrasonography (US) remains the most commonly applied method in the preliminary assessment of lesions and forms the basis for the decision as to fine needle aspiration biopsy (FNAB) and further diagnostics.
Numerous studies have evaluated the diagnostic value of sonographic malignancy features. However, they have focused mainly on papillary thyroid cancer (PTC) as the most frequent thyroid malignancy [3] [4] [5] . The controversial issue is whether other types of thyroid carcinoma (TC), such as medullary thyroid cancer (MTC), are also characterised by the same US features.
MTC accounts for 3.5-10% of all TCs [6] . It derives from the parafollicular C-cells, which produce the hormone calcitonin. About 75% of MTCs are sporadic and 25% are hereditary cases [7] . This tumour is usually difficult to diagnose, and consequently 35% of patients at the time of diagnosis have MTC extending beyond the thyroid [8] . Routine measurement of calcitonin level is not commonly used in diagnosing patients with thyroid nodules because of the high cost [9] . Thus there arises a question about the US appearance of MTCs which is crucial in the initial steps of diagnostics.
The aim of this study was to assess the usefulness of ultrasound features considered to be markers of malignancy in the diagnosis of medullary thyroid cancer.
Material and methods

Literature search and data extraction
We searched the PubMed/MEDLINE and Cochrane Library databases in order to identify all relevant research articles. The search terms 'medullary thyroid cancer' or 'medullary thyroid carcinoma' and ultrasound or ultrasonography or elastography or 'power Doppler' or 'color Doppler' were used. The following filters were applied -English language and publication between January 2000 and May 2013. The literature search was performed independently by two authors (K.W. and M.R-Ł.). All papers, including data on US, ES and Doppler examination features of histhopatologically confirmed MTCs, were included.
Statistical analysis
Pooled sensitivities and specificities of particular markers of malignancy were calculated using a randomeffect model according to the methodology described by Borenstein et al. [10] . Results of studies comparing frequencies of particular features in MTCs and PTCs were combined using Statistica v. 10 from StatSoft. A P value under 0.05 was considered statistically significant. Meta-analysis was performed if at least three studies provided data on a particular marker of malignancy.
Results
Six studies containing data on sonographic features of 169 MTCs were included into the meta-analysis (Table I ). All these studies had a retrospective character. Three of them encompassed also comparisons with PTCs, and two with benign thyroid nodules. The steps of selection are shown on the flowchart (Fig. 1) . Results of included studies on the US appearance of MTCs are summarised in Table II .
Hypoechogenicity
Five studies containing data on 157 MTCs provided data on the occurrence of hypoechogenicity. The pooled frequency was 83.4% (95% CI 46.5-100.0%). There was no evidence for significant heterogeneity (Q = 0.11, p = 1.0). Three studies included comparisons between MTCs and PTCs. Pooled OR was 0.97 (95% CI 0.64 -1.46). There was no evidence for significant heterogeneity (Q = 0.03, p = 0.98). None of the 157 MTCs was hyperechogenic. 
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Marked hypoechogenicity
Four studies containing data on 134 MTCs provided data on the occurrence of marked hypoechogenicity. The pooled frequency was 32.7% (95% CI 21.8-49.1%).
There was no evidence for significant heterogeneity (Q = 3.01, p = 0.39). Two studies included comparisons between MTCs and PTCs [3, 4] . Both showed that marked hypoechogenicity was insignificantly less frequent in MTCs.
Microcalcifications
Six studies containing data on 169 MTCs provided data on the occurrence of microcalcifications. The pooled frequency was 35.5% (95% CI 25.8-49.0%). There was no evidence for significant heterogeneity (Q = 0.00, p = 1.0). Three studies included comparisons between MTCs and PTCs. Pooled OR was 0.64 (95% CI 0.38-1.10). There was no evidence for significant heterogeneity (Q = 4.27, p = 0.12).
Macrocalcifications
Six studies containing data on 169 MTCs provided data on the occurrence of macrocalcifications. The pooled frequency was 27.0% (95% CI 18.3-39.8%). There was no evidence for significant heterogeneity (Q = 3.74, p = 0.59). Three studies included comparisons between MTCs and PTCs. Pooled OR was 1.77 (95% CI 0.83-3.79).
There was no evidence for significant heterogeneity (Q = 1.44, p = 0.49).
Absent or irregular halo
Three studies containing data on 66 MTCs provided data on the occurrence of halo irregularity or absence. The pooled frequency was 89.9% (95% CI 31.9-100.0%). There was no evidence for significant heterogeneity (Q = 0.00, p = 1.00). One study included a comparison between MTCs and PTCs [5] . It showed that halo absence was insignificantly less frequent in MTCs (p = 0.06).
Solid composition
Six studies containing data on 169 MTCs provided data on the occurrence of solid composition. The pooled frequency was 79.2% (95% CI 51.8-100.0%). There was no evidence for significant heterogeneity (Q = 0.25, p = 1.00). Three studies included comparisons between MTCs and PTCs. Pooled OR was 0.79 (95% CI 0.52-1.18). There was no evidence for significant heterogeneity (Q = 0.43, p = 0.80). There were no pure cystic MTCs, and only one predominantly cystic MTC, reported in the included studies. 
Discussion
Hypoechogenicity, halo absence, and solid composition are the most common sonographic features of MTCs. Also calcifications are frequent findings in MTCs. Microcalcifications occurred in 35.5%, and macrocalcifications in a further 27.0%. Irregular margins were moderately common (38.0%) in MTCs; however, there was significant heterogeneity due to the great dispersion of results of particular studies -from 0% [5] to nearly 50% [11] . Partly this could be the effect of the small number of studies assessing this feature. Furthermore, this attribute has been described by some authors as being characterised by low intra-and interobserver agreement [12, 13] . The 'taller than wide' feature turned out to be rarely present in MTCs.
The amount of available data on the US features of MTCs is low. Six included studies contained descriptions of 169 MTCs. As the panels of assessed features were partly different in particular studies, the amount of information about some of the markers is even lower. There was not enough data on Colour Doppler (CD) and Power Doppler (PD) examinations to meta-analyse. However, a few studies contained some information on this topic. Trimboli et al. [5] reported that three of 12 MTCs presented intranodular flow in CD. According to Cai et al. [14] , seven of 29 examined cancers had strong intranodular flow, and 15 had moderate flow. Saller et al. [15] assessed the usefulness of PD: intranodular flow was present in six of 14 examined MTCs, and intranodular flow with concomitant perinodular signal in a further five tumours. We did not find any study containing information about the appearance of MTCs in soelastography, which is believed to be an important improvement on conventional US. This has been described as a valuable tool in differentiating between benign and malignant thyroid nodules [16, 17] , diagnostic of other thyroid diseases, such as Graves' disease, chronic or subacute thyroiditis [18] [19] [20] .
Three studies compared the occurrence of these markers of malignancy in MTCs and PTCs, including data on 79 MTCs and 208 PTCs. Macrocalcifications were slightly more frequent in MTCs, hypoechogenicity occurred in fact equally often in both groups (OR = 0.97), and all other meta-analysed features were somewhat less common in MTCs. However, none of these differences achieved statistical significance. This is probably partly due to the small number of studies and investigated cancers. Commonly used US markers, apart from macrocalcifications and hypoechogenicity, seem to be less sensitive in the diagnostics of MTCs, but further studies are needed to reach a definite conclusion. Most studies did not compare the US appearance of sporadic and hereditary MTCs. The study performed by Saller et al. did not reveal significant differences, although it encompassed only ten patients with sporadic MTC, seven with MEN 2A, and two with MEN 2B [15] .
According to our results, typical MTC appears as a solid, hypoechogenic (often markedly) lesion without a halo and quite commonly containing micro-or macrocalcifications. However, the first three features are known to be very unspecific [21, 22] , and the other two are less sensitive. In our opinion, the presence of a lesion with the appearance described above should arouse a suspicion of MTC and should be considered as an argument for further diagnostic steps, such as calcitonin measurement. On the other hand, most MTCs do not present all of the above features, and some of them can have a relatively benign US appearance. Particularly in cases of family history of MTC, the absence of the abovementioned US malignancy features is insufficient to exclude this type of malignancy. However, some attributes can be considered as markers of benign status. Especially hyperechogenicity and pure or predominantly cystic character seem to be extremely uncommon in MTCs. Isoechogenicity, halo presence, and minor cystic components also decrease the risk that a particular tumour is MTC, as these features are present in about 10% to 20% of MTCs.
In conclusion, US features commonly considered as markers of malignancy can be useful also in diagnosing MTCs. However, MTCs tends to possess suspicious US features slightly less often than PTCs. Some features, such as hyperechogenicity, strongly decrease the risk of MTC. Although the US appearance of the thyroid lesion
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is an important diagnostic factor, it is worth remembering that it does not allow for a definitive differentiation between benign and malignant nodules. In a case of MTC, as well as other TCs, US examination remains a valuable diagnostic tool, but it should always be interpreted carefully in the context of other examinations.
